Best Pharmaceutical Stocks To Consider – February 09th

Eli Lilly and Company, Merck & Co., Inc., and Honeywell International are the three Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks refer to shares of publicly traded companies that operate within the pharmaceutical industry. These companies are involved in the research, development, production, and commercialization of pharmaceutical drugs and healthcare products. Investing in pharmaceutical stocks allows investors to gain exposure to this sector and potentially benefit from the growth and profitability of these companies. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of NYSE:LLY traded up $7.72 during midday trading on Friday, reaching $878.09. 4,421,566 shares of the company’s stock traded hands, compared to its average volume of 4,056,943. Eli Lilly and Company has a one year low of $711.40 and a one year high of $972.53. The stock has a 50 day moving average of $789.87 and a 200 day moving average of $843.31. The company has a market cap of $833.59 billion, a price-to-earnings ratio of 74.99, a P/E/G ratio of 1.87 and a beta of 0.42. The company has a debt-to-equity ratio of 2.03, a quick ratio of 0.97 and a current ratio of 1.27.

Read Our Latest Research Report on LLY

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

MRK traded down $0.79 during midday trading on Friday, hitting $87.26. 15,806,931 shares of the company traded hands, compared to its average volume of 14,162,434. The company’s 50-day moving average is $98.72 and its 200 day moving average is $106.48. Merck & Co., Inc. has a 52 week low of $87.12 and a 52 week high of $134.63. The firm has a market capitalization of $220.73 billion, a PE ratio of 12.97, a price-to-earnings-growth ratio of 0.83 and a beta of 0.38. The company has a quick ratio of 1.15, a current ratio of 1.36 and a debt-to-equity ratio of 0.79.

Read Our Latest Research Report on MRK

Honeywell International (HON)

Honeywell International Inc. engages in the aerospace technologies, building automation, energy and sustainable solutions, and industrial automation businesses in the United States, Europe, and internationally. The company’s Aerospace segment offers auxiliary power units, propulsion engines, integrated avionics, environmental control and electric power systems, engine controls, flight safety, communications, navigation hardware, data and software applications, radar and surveillance systems, aircraft lighting, advanced systems and instruments, satellite and space components, and aircraft wheels and brakes; spare parts; repair, overhaul, and maintenance services; and thermal systems, as well as wireless connectivity services.

Honeywell International stock traded down $4.30 during midday trading on Friday, reaching $205.52. 6,694,143 shares of the company traded hands, compared to its average volume of 3,948,731. The company has a debt-to-equity ratio of 1.33, a current ratio of 1.31 and a quick ratio of 1.12. Honeywell International has a 12 month low of $189.75 and a 12 month high of $242.77. The firm has a market capitalization of $133.64 billion, a price-to-earnings ratio of 23.60, a price-to-earnings-growth ratio of 2.55 and a beta of 1.05. The business has a 50 day moving average of $224.52 and a two-hundred day moving average of $215.10.

Read Our Latest Research Report on HON

See Also